Switch to:
Also traded in: Germany, USA

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.01
UHS's Cash-to-Debt is ranked lower than
99% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 0.32 vs. UHS: 0.01 )
Ranked among companies with meaningful Cash-to-Debt only.
UHS' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.01 Max: 0.04
Current: 0.01
0
0.04
Equity-to-Asset 0.44
UHS's Equity-to-Asset is ranked lower than
53% of the 216 Companies
in the Global Medical Care industry.

( Industry Median: 0.46 vs. UHS: 0.44 )
Ranked among companies with meaningful Equity-to-Asset only.
UHS' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.26  Med: 0.41 Max: 0.49
Current: 0.44
0.26
0.49
Interest Coverage 10.61
UHS's Interest Coverage is ranked higher than
60% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 7.01 vs. UHS: 10.61 )
Ranked among companies with meaningful Interest Coverage only.
UHS' s Interest Coverage Range Over the Past 10 Years
Min: 4.46  Med: 8.27 Max: 48.57
Current: 10.61
4.46
48.57
Piotroski F-Score: 6
Altman Z-Score: 3.28
Beneish M-Score: -2.69
WACC vs ROIC
6.61%
10.37%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 13.12
UHS's Operating Margin % is ranked higher than
72% of the 218 Companies
in the Global Medical Care industry.

( Industry Median: 6.53 vs. UHS: 13.12 )
Ranked among companies with meaningful Operating Margin % only.
UHS' s Operating Margin % Range Over the Past 10 Years
Min: 7.91  Med: 13.04 Max: 13.93
Current: 13.12
7.91
13.93
Net Margin % 7.19
UHS's Net Margin % is ranked higher than
66% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 4.07 vs. UHS: 7.19 )
Ranked among companies with meaningful Net Margin % only.
UHS' s Net Margin % Range Over the Past 10 Years
Min: 3.64  Med: 6.13 Max: 7.53
Current: 7.19
3.64
7.53
ROE % 16.13
UHS's ROE % is ranked higher than
77% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 9.23 vs. UHS: 16.13 )
Ranked among companies with meaningful ROE % only.
UHS' s ROE % Range Over the Past 10 Years
Min: 11.67  Med: 15.9 Max: 18.63
Current: 16.13
11.67
18.63
ROA % 7.21
UHS's ROA % is ranked higher than
73% of the 222 Companies
in the Global Medical Care industry.

( Industry Median: 3.61 vs. UHS: 7.21 )
Ranked among companies with meaningful ROA % only.
UHS' s ROA % Range Over the Past 10 Years
Min: 4.01  Med: 5.89 Max: 7.32
Current: 7.21
4.01
7.32
ROC (Joel Greenblatt) % 28.85
UHS's ROC (Joel Greenblatt) % is ranked higher than
65% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 15.77 vs. UHS: 28.85 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
UHS' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 15.92  Med: 23.41 Max: 29.12
Current: 28.85
15.92
29.12
3-Year Revenue Growth Rate 10.20
UHS's 3-Year Revenue Growth Rate is ranked higher than
58% of the 182 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. UHS: 10.20 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
UHS' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 4.6  Med: 11.5 Max: 17.3
Current: 10.2
4.6
17.3
3-Year EBITDA Growth Rate 11.60
UHS's 3-Year EBITDA Growth Rate is ranked higher than
58% of the 162 Companies
in the Global Medical Care industry.

( Industry Median: 7.80 vs. UHS: 11.60 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
UHS' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -3.3  Med: 14.1 Max: 26.7
Current: 11.6
-3.3
26.7
3-Year EPS without NRI Growth Rate 11.60
UHS's 3-Year EPS without NRI Growth Rate is ranked higher than
57% of the 136 Companies
in the Global Medical Care industry.

( Industry Median: 8.40 vs. UHS: 11.60 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
UHS' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -11.3  Med: 14.3 Max: 31
Current: 11.6
-11.3
31
GuruFocus has detected 3 Warning Signs with Universal Health Services Inc $UHS.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» UHS's 10-Y Financials

Financials (Next Earnings Date: 2017-05-28 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

UHS Guru Trades in Q1 2016

Paul Tudor Jones 3,517 sh (New)
Andreas Halvorsen 429,887 sh (New)
John Paulson 54,000 sh (New)
Jeremy Grantham 20,700 sh (+30.19%)
Lee Ainslie 966,544 sh (+21.45%)
Jim Simons 215,000 sh (+19.98%)
Robert Olstein 34,000 sh (+6.25%)
RS Investment Management 227,613 sh (+1.25%)
Chris Davis 97,650 sh (+0.18%)
Vanguard Health Care Fund 3,939,340 sh (unchged)
Larry Robbins Sold Out
Steven Cohen 19,800 sh (-2.46%)
Westport Asset Management 571,391 sh (-8.05%)
Ron Baron 197,664 sh (-26.79%)
Private Capital 140,550 sh (-35.87%)
Joel Greenblatt 166,650 sh (-56.58%)
» More
Q2 2016

UHS Guru Trades in Q2 2016

Ray Dalio 1,500 sh (New)
Lee Ainslie 2,768,938 sh (+186.48%)
Joel Greenblatt 334,501 sh (+100.72%)
Paul Tudor Jones 3,571 sh (+1.54%)
Vanguard Health Care Fund 3,939,340 sh (unchged)
Chris Davis Sold Out
Andreas Halvorsen Sold Out
John Paulson Sold Out
Ron Baron 195,584 sh (-1.05%)
Private Capital 121,825 sh (-13.32%)
RS Investment Management 184,694 sh (-18.86%)
Robert Olstein 24,000 sh (-29.41%)
Westport Asset Management 400,827 sh (-29.85%)
Jeremy Grantham 13,000 sh (-37.20%)
Jim Simons 108,100 sh (-49.72%)
Steven Cohen 2,700 sh (-86.36%)
» More
Q3 2016

UHS Guru Trades in Q3 2016

Jana Partners 1,273,646 sh (New)
Larry Robbins 950,390 sh (New)
Andreas Halvorsen 1,929,192 sh (New)
Jim Simons 248,900 sh (+130.25%)
Lee Ainslie 4,584,358 sh (+65.56%)
Robert Olstein 34,000 sh (+41.67%)
Vanguard Health Care Fund 3,939,340 sh (unchged)
Ray Dalio Sold Out
Jeremy Grantham Sold Out
Steven Cohen Sold Out
Private Capital 119,170 sh (-2.18%)
Ron Baron 189,684 sh (-3.02%)
Joel Greenblatt 295,558 sh (-11.64%)
Paul Tudor Jones 2,200 sh (-38.39%)
» More
Q4 2016

UHS Guru Trades in Q4 2016

Paul Tudor Jones 12,393 sh (+463.32%)
Larry Robbins 1,762,915 sh (+85.49%)
Robert Olstein 57,000 sh (+67.65%)
Jana Partners 2,051,970 sh (+61.11%)
Lee Ainslie 6,130,994 sh (+33.74%)
Vanguard Health Care Fund 4,527,240 sh (+14.92%)
Private Capital 109,139 sh (-8.42%)
Ron Baron 156,224 sh (-17.64%)
Joel Greenblatt 182,778 sh (-38.16%)
Andreas Halvorsen 350,693 sh (-81.82%)
Jim Simons 16,400 sh (-93.41%)
» More
» Details

Insider Trades

Latest Guru Trades with UHS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 622110    SIC: 8062
Compare:NAS:BIOS » details
Traded in other countries:UHS.Germany, UHID.USA,
Universal Health Services Inc, through its subsidiaries is engaged in the business of owning and operating acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers.

Universal Health Services owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two key segments: Acute Care Hospital Services and Behavioral Health Services. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers. Each segment contributes roughly half of the firm's overall revenue. Universal Health Services receives a significant portion of its net patient revenue from Medicare and Medicaid. The largest proportion of the firm's net patient revenue is paid by managed care organizations.

Guru Investment Theses on Universal Health Services Inc

Baron Funds Comments on Universal Health Services Inc. - Aug 18, 2015

Universal Health Services, Inc. (NYSE:UHS) is a leading operator of acute care hospitals, and it is also the country’s largest provider of behavioral health services. The company’s shares rose sharply in late-June in response to the U.S. Supreme Court’s decision to uphold a key provision of the Affordable Care Act (ACA), which has expanded insurance coverage to almost 13 million Americans. The court’s decision removes meaningful future legal challenges to the ACA, which has driven a meaningful increase in hospital utilization. This court decision came on the heels of solid quarterly earnings results. As the dominant acute care provider in some of the fastest growing markets in the U.S., we continue to like Universal’s positioning and prospects. We are particularly excited about the opportunity for its behavioral health business to gain more favorable reimbursement treatment for Medicaid patients.



From Baron Funds' second quarter commentary.



Check out Ron Baron latest stock trades

Westport Select Cap Fund Comments on Universal Health Services Inc - May 29, 2015

Universal Health Services, Inc., Class B shares (UHS), the fund’s largest position, was up nearly 6%, contributing 79 basis points. The company continues to benefit from the Affordable Care Actii (“Obamacare“) as it reported strong fourth quarter results and forecast continued above average growth for 2015.

From Westport Asset Management (Trades, Portfolio)’s Westport Select Cap Fund Q1 2015 Commentary.

Check out Westport Asset Management latest stock trades

Top Ranked Articles about Universal Health Services Inc

Westport's Top 7 Transactions in 2nd Quarter Were Reductions Firm sells 30% of position in Universal Health Services
Westport Asset Management (Trades, Portfolio)’s top seven transactions in the second quarter were reductions of stakes in its portfolio. Read more...

Ratios

vs
industry
vs
history
PE Ratio 17.55
UHS's PE Ratio is ranked higher than
77% of the 279 Companies
in the Global Medical Care industry.

( Industry Median: 28.41 vs. UHS: 17.55 )
Ranked among companies with meaningful PE Ratio only.
UHS' s PE Ratio Range Over the Past 10 Years
Min: 8.1  Med: 15.18 Max: 25.04
Current: 17.55
8.1
25.04
Forward PE Ratio 15.85
UHS's Forward PE Ratio is ranked higher than
77% of the 98 Companies
in the Global Medical Care industry.

( Industry Median: 19.01 vs. UHS: 15.85 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 17.55
UHS's PE Ratio without NRI is ranked higher than
76% of the 235 Companies
in the Global Medical Care industry.

( Industry Median: 27.34 vs. UHS: 17.55 )
Ranked among companies with meaningful PE Ratio without NRI only.
UHS' s PE Ratio without NRI Range Over the Past 10 Years
Min: 8.26  Med: 15.14 Max: 25.26
Current: 17.55
8.26
25.26
Price-to-Owner-Earnings 13.49
UHS's Price-to-Owner-Earnings is ranked higher than
81% of the 97 Companies
in the Global Medical Care industry.

( Industry Median: 28.18 vs. UHS: 13.49 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
UHS' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 7.73  Med: 15.16 Max: 186.83
Current: 13.49
7.73
186.83
PB Ratio 2.67
UHS's PB Ratio is ranked lower than
54% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 2.42 vs. UHS: 2.67 )
Ranked among companies with meaningful PB Ratio only.
UHS' s PB Ratio Range Over the Past 10 Years
Min: 1.01  Med: 2.13 Max: 3.54
Current: 2.67
1.01
3.54
PS Ratio 1.27
UHS's PS Ratio is ranked higher than
60% of the 270 Companies
in the Global Medical Care industry.

( Industry Median: 1.55 vs. UHS: 1.27 )
Ranked among companies with meaningful PS Ratio only.
UHS' s PS Ratio Range Over the Past 10 Years
Min: 0.33  Med: 0.78 Max: 1.68
Current: 1.27
0.33
1.68
Price-to-Free-Cash-Flow 16.53
UHS's Price-to-Free-Cash-Flow is ranked higher than
72% of the 134 Companies
in the Global Medical Care industry.

( Industry Median: 26.27 vs. UHS: 16.53 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
UHS' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 8.37  Med: 15.75 Max: 325.73
Current: 16.53
8.37
325.73
Price-to-Operating-Cash-Flow 9.58
UHS's Price-to-Operating-Cash-Flow is ranked higher than
74% of the 191 Companies
in the Global Medical Care industry.

( Industry Median: 14.39 vs. UHS: 9.58 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
UHS' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 3.21  Med: 8.46 Max: 23.76
Current: 9.58
3.21
23.76
EV-to-EBIT 12.73
UHS's EV-to-EBIT is ranked higher than
78% of the 290 Companies
in the Global Medical Care industry.

( Industry Median: 19.26 vs. UHS: 12.73 )
Ranked among companies with meaningful EV-to-EBIT only.
UHS' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.2  Med: 11.1 Max: 17.1
Current: 12.73
6.2
17.1
EV-to-EBITDA 9.61
UHS's EV-to-EBITDA is ranked higher than
74% of the 303 Companies
in the Global Medical Care industry.

( Industry Median: 14.06 vs. UHS: 9.61 )
Ranked among companies with meaningful EV-to-EBITDA only.
UHS' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.3  Med: 7.8 Max: 12.1
Current: 9.61
4.3
12.1
PEG Ratio 2.26
UHS's PEG Ratio is ranked higher than
62% of the 90 Companies
in the Global Medical Care industry.

( Industry Median: 3.02 vs. UHS: 2.26 )
Ranked among companies with meaningful PEG Ratio only.
UHS' s PEG Ratio Range Over the Past 10 Years
Min: 0.41  Med: 1.04 Max: 4.09
Current: 2.26
0.41
4.09
Shiller PE Ratio 28.49
UHS's Shiller PE Ratio is ranked higher than
52% of the 46 Companies
in the Global Medical Care industry.

( Industry Median: 28.27 vs. UHS: 28.49 )
Ranked among companies with meaningful Shiller PE Ratio only.
UHS' s Shiller PE Ratio Range Over the Past 10 Years
Min: 10.2  Med: 21.8 Max: 40.68
Current: 28.49
10.2
40.68
Current Ratio 1.28
UHS's Current Ratio is ranked higher than
50% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 1.28 vs. UHS: 1.28 )
Ranked among companies with meaningful Current Ratio only.
UHS' s Current Ratio Range Over the Past 10 Years
Min: 1.16  Med: 1.58 Max: 1.91
Current: 1.28
1.16
1.91
Quick Ratio 1.18
UHS's Quick Ratio is ranked higher than
51% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 1.18 vs. UHS: 1.18 )
Ranked among companies with meaningful Quick Ratio only.
UHS' s Quick Ratio Range Over the Past 10 Years
Min: 1.06  Med: 1.46 Max: 1.73
Current: 1.18
1.06
1.73
Days Inventory 42.29
UHS's Days Inventory is ranked lower than
75% of the 161 Companies
in the Global Medical Care industry.

( Industry Median: 18.72 vs. UHS: 42.29 )
Ranked among companies with meaningful Days Inventory only.
UHS' s Days Inventory Range Over the Past 10 Years
Min: 8.44  Med: 26.29 Max: 44.68
Current: 42.29
8.44
44.68
Days Sales Outstanding 53.80
UHS's Days Sales Outstanding is ranked lower than
65% of the 179 Companies
in the Global Medical Care industry.

( Industry Median: 44.02 vs. UHS: 53.80 )
Ranked among companies with meaningful Days Sales Outstanding only.
UHS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42.28  Med: 53.19 Max: 62.41
Current: 53.8
42.28
62.41
Days Payable 155.60
UHS's Days Payable is ranked higher than
80% of the 143 Companies
in the Global Medical Care industry.

( Industry Median: 40.41 vs. UHS: 155.60 )
Ranked among companies with meaningful Days Payable only.
UHS' s Days Payable Range Over the Past 10 Years
Min: 20.14  Med: 71.34 Max: 155.6
Current: 155.6
20.14
155.6

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.32
UHS's Dividend Yield % is ranked lower than
95% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 1.65 vs. UHS: 0.32 )
Ranked among companies with meaningful Dividend Yield % only.
UHS' s Dividend Yield % Range Over the Past 10 Years
Min: 0.17  Med: 0.45 Max: 0.99
Current: 0.32
0.17
0.99
Dividend Payout Ratio 0.06
UHS's Dividend Payout Ratio is ranked higher than
99% of the 145 Companies
in the Global Medical Care industry.

( Industry Median: 0.39 vs. UHS: 0.06 )
Ranked among companies with meaningful Dividend Payout Ratio only.
UHS' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.04  Med: 0.06 Max: 0.1
Current: 0.06
0.04
0.1
3-Year Dividend Growth Rate 26.00
UHS's 3-Year Dividend Growth Rate is ranked higher than
76% of the 79 Companies
in the Global Medical Care industry.

( Industry Median: 10.10 vs. UHS: 26.00 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
UHS' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 58.7
Current: 26
0
58.7
Forward Dividend Yield % 0.32
UHS's Forward Dividend Yield % is ranked lower than
96% of the 231 Companies
in the Global Medical Care industry.

( Industry Median: 1.84 vs. UHS: 0.32 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 0.75
UHS's 5-Year Yield-on-Cost % is ranked lower than
86% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 2.17 vs. UHS: 0.75 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
UHS' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.4  Med: 1.05 Max: 2.31
Current: 0.75
0.4
2.31
3-Year Average Share Buyback Ratio 0.60
UHS's 3-Year Average Share Buyback Ratio is ranked higher than
84% of the 129 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. UHS: 0.60 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
UHS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -0.7  Med: 1.8 Max: 3.6
Current: 0.6
-0.7
3.6

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 16.16
UHS's Price-to-Tangible-Book is ranked lower than
91% of the 223 Companies
in the Global Medical Care industry.

( Industry Median: 4.00 vs. UHS: 16.16 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
UHS' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.35  Med: 4.88 Max: 39.76
Current: 16.16
2.35
39.76
Price-to-Intrinsic-Value-Projected-FCF 1.15
UHS's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
81% of the 137 Companies
in the Global Medical Care industry.

( Industry Median: 2.07 vs. UHS: 1.15 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
UHS' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.79  Med: 1.14 Max: 4.15
Current: 1.15
0.79
4.15
Price-to-Intrinsic-Value-DCF (Earnings Based) 0.79
UHS's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
96% of the 51 Companies
in the Global Medical Care industry.

( Industry Median: 1.83 vs. UHS: 0.79 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.62
UHS's Price-to-Median-PS-Value is ranked lower than
78% of the 246 Companies
in the Global Medical Care industry.

( Industry Median: 1.09 vs. UHS: 1.62 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
UHS' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.49  Med: 1.15 Max: 2.05
Current: 1.62
0.49
2.05
Price-to-Peter-Lynch-Fair-Value 2.14
UHS's Price-to-Peter-Lynch-Fair-Value is ranked higher than
55% of the 80 Companies
in the Global Medical Care industry.

( Industry Median: 2.23 vs. UHS: 2.14 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
UHS' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.48  Med: 1.37 Max: 2.6
Current: 2.14
0.48
2.6
Price-to-Graham-Number 3.55
UHS's Price-to-Graham-Number is ranked lower than
64% of the 165 Companies
in the Global Medical Care industry.

( Industry Median: 2.50 vs. UHS: 3.55 )
Ranked among companies with meaningful Price-to-Graham-Number only.
UHS' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.02  Med: 2.19 Max: 5.29
Current: 3.55
1.02
5.29
Earnings Yield (Greenblatt) % 7.84
UHS's Earnings Yield (Greenblatt) % is ranked higher than
81% of the 332 Companies
in the Global Medical Care industry.

( Industry Median: 4.31 vs. UHS: 7.84 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
UHS' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 5.8  Med: 9 Max: 16.1
Current: 7.84
5.8
16.1
Forward Rate of Return (Yacktman) % 13.17
UHS's Forward Rate of Return (Yacktman) % is ranked higher than
62% of the 119 Companies
in the Global Medical Care industry.

( Industry Median: 10.14 vs. UHS: 13.17 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
UHS' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 9.8  Med: 18.7 Max: 28
Current: 13.17
9.8
28

More Statistics

Revenue (TTM) (Mil) $9,766
EPS (TTM) $ 7.14
Beta0.75
Short Percentage of Float2.62%
52-Week Range $99.72 - 139.77
Shares Outstanding (Mil)96.60

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 11,306 11,995 12,837
EPS ($) 7.92 8.77 9.55
EPS without NRI ($) 7.92 8.77 9.55
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($) 0.40 0.40 0.40
» More Articles for UHS

Headlines

Articles On GuruFocus.com
Steven Romick Spots Next Area of Interest, Health Care Jan 13 2017 
Can Universal Health Services Power Past the Political Turbulence? Nov 30 2016 
Andreas Halvorsen’s Top 3 New Holdings Nov 16 2016 
Low P/S Stocks: The Travelers, AIG Sep 20 2016 
Westport's Top 7 Transactions in 2nd Quarter Were Reductions Sep 06 2016 
Healthcare Dividend Growth Stocks: Part 1 Aug 04 2016 
Westport Funds' Final Quarterly Commentary Jul 19 2016 
Quality Guru Stocks Include Amgen, Comcast Apr 21 2016 
Westport Trims Nearly 39% of Stakes in Portfolio Feb 12 2016 
Westport Select Cap Fund Third Quarter Commentary Oct 16 2015 

More From Other Websites
Which Hospital Stocks Are Expected to Benefit Most? Mar 28 2017
Universal Health Services Upgraded at Mizuho, Stock Rises as Obamacare Remains Mar 27 2017
TrumpCare is Dead. These Stocks Have Sprung to Life. Mar 27 2017
Universal Health upgraded by Mizuho Mar 27 2017
Healthcare stocks that benefitted from Obamacare spike after 'Trumpcare' vote gets pulled Mar 24 2017
The health-care stocks making moves before the GOP vote Mar 24 2017
Best bets in health care stocks: Pro Mar 24 2017
If AHCA bill passes, it will be negative for hospital sto... Mar 23 2017
Universal Health Services, Inc. breached its 50 day moving average in a Bullish Manner : UHS-US :... Mar 23 2017
Is Universal Health Services a Good Pick for Value Investors? Mar 22 2017
Is it Wise to Hold Universal Health (UHS) in Your Portfolio? Mar 15 2017
Universal Health Services, Inc. to Present at the Barclays Global Healthcare Conference Mar 10 2017
The Zacks Analyst Blog Highlights: Acadia Healthcare, VCA, Universal Health Services and Mednax Mar 09 2017
Obamacare Replacement: A Threat to Hospital Stocks? Mar 08 2017
Stocks: Ready for Trump rally rebound or third straight down day and bigger retreat from Dow 21K? Mar 07 2017
Healthcare stocks slide after the GOP releases its plan to repeal Obamacare Mar 07 2017
2 Reasons Universal Health Systems Has A Clear Path To Growth Mar 06 2017
UNIVERSAL HEALTH SERVICES INC Financials Mar 04 2017
Universal Health Services, Inc. :UHS-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2, 2017 Mar 02 2017
Edited Transcript of UHS earnings conference call or presentation 1-Mar-17 2:00pm GMT Mar 01 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)